- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04421690
Computerized Cognitive Training in Middle-Aged Adults With Generalized Anxiety Disorder: A Pilot Study (COGMA)
March 14, 2023 updated by: Ashley Curtis, University of Missouri-Columbia
Computerized Cognitive Training in Middle-Aged Adults With Generalized Anxiety Disorder: A Pilot Study (COGMA)
The purpose of this research is to look at the effects of computerized cognitive training on anxiety, sleep, mental abilities (cognition), and other aspects of daytime functioning, such as arousal.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Missouri
-
Columbia, Missouri, United States, 65201
- University of Missouri
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 59 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 45-59 yrs of age
- no neurological or psychiatric illness, dementia, or loss of consciousness > 5 mins
- nongamers (i.e., report <1 hour of video/cognitive training games/week over last 2 yrs)
- proficient in English (reading and writing)
- computer meets technology requirements (i.e. Windows: Windows 7 or above using Internet Explorer 11 or Edge, Mozilla Firefox 41 and above, Google Chrome 48 and above; Mac OS: Mac OS X v10.8 and above using Safari 10 and above, Mozilla Firefox 42 and above, Google Chrome 48 and above; Android App: Android 6 or higher version; iOS App: iOS 10 or higher version
- meet clinical dx criteria for Generalized Anxiety Disorder.
Exclusion Criteria:
- unable to provide informed consent
- unable to undergo randomization
- Telephone Interview for Cognitive Status-modified (TICS) score <33, 2)
- other sleep disorder (i.e., sleep apnea, Periodic Limb Movement Disorder-PLMD, narcolepsy, REM Sleep Behavior Disorder)
- severe untreated psychiatric comorbidity that renders randomization unethical
- psychotropic, anxiolytic medications or other medications(e.g., beta-blockers) that alter mood or sleep
- uncorrected visual/auditory impairments
- participation in nonpharmacological treatment for sleep/fatigue/mood outside the current study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Cognitive Training
8 week computerized cognitive training
|
Participants (n=15) will complete computerized cognitive training games and activities online 3 times/week for 8 weeks.
|
Active Comparator: Trivia Training
8 week computerized trivia training
|
Participants (n=15) will receive computerized trivia questions to answer and submit 3 times/week for 8 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Objective Cognition - Computerized Cognitive Tasks
Time Frame: Up to 10 weeks
|
Complete computerized tasks.
These tasks will measure cognitive functions (e.g., processing speed).
|
Up to 10 weeks
|
Objective Cognition - Computerized Cognitive Tasks
Time Frame: Up to 10 weeks
|
Complete computerized tasks.
These tasks will measure cognitive functions (e.g., attention).
|
Up to 10 weeks
|
Objective Cognition - Computerized Cognitive Tasks
Time Frame: Up to 10 weeks
|
Complete computerized tasks.
These tasks will measure cognitive functions (e.g., executive function).
|
Up to 10 weeks
|
Subjective Cognitive Self-Efficacy. -Cognitive Failures Questionnaire
Time Frame: Up to 10 weeks
|
A 25-item questionnaire.
Participants rate from 0 (never) to 4 (very often) frequency of cognitive errors.
Higher scores indicate lower cognitive self-efficacy.
|
Up to 10 weeks
|
Coronavirus Anxiety Scale
Time Frame: Up to 10 weeks
|
5- item questionnaire that assess anxiety related to the Coronavirus.
|
Up to 10 weeks
|
Anxiety - State-Trait Anxiety Inventory
Time Frame: Up to 10 weeks
|
Inventory that asks respondents to rate how true 20 self-descriptive statements (e.g., I feel calm) are on a 4-point scale (1 = not at all, 4 = very much so).
Typically, respondents are asked to rate statements according to how they generally feel (trait-anxiety scale) and how they feel in the current moment (state-anxiety scale).
Total scores range from 20 to 80, with higher scores indicating greater maladjustment.
|
Up to 10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Game-related experience- Sessions and duration played
Time Frame: Up to 10 weeks
|
During the intervention phase the cognitive training group will play games and will need to log the days and duration played.
|
Up to 10 weeks
|
Circadian Rhythm- Morningness-Eveningness Questionnaire
Time Frame: Up to 10 weeks
|
19-item questionnaire that assesses preference for morning, afternoon, and evening activities.
Total score reflects degree of "morningness" or "eveningness" type.
|
Up to 10 weeks
|
Subjective Arousal- Global Cognitive Arousal-Perceived Stress Scale
Time Frame: Up to 10 weeks
|
Perceived Stress Scale is a self-report measure of how life situations are perceived as stressful.
The scale consists of 15 items corresponding to everyday situation and participants are asked to rate on a likert scale from 0 (never) to 4 (very often) how often they felt or thought a specific way.
Higher scores correspond to higher perceived stress.
|
Up to 10 weeks
|
Subjective Arousal- Pre-sleep Arousal Scale
Time Frame: Up to 10 weeks
|
Pre-sleep Arousal Scale is a 16-item self-report questionnaire comprising both cognitive and somatic manifestations of arousal.
|
Up to 10 weeks
|
Subjective Arousal- Arousal Predisposition Scale Subjective Arousal- Arousal Predisposition Scale Subjective Arousal- Arousal Predisposition Scale
Time Frame: Up to 10 weeks
|
Arousal Predisposition Scale is a 12-item inventory that has been designed to measure the degree to which an individual experiences arousal.
Higher scores indicate greater predisposition to arousal.
|
Up to 10 weeks
|
Game Engagement Questionnaire
Time Frame: Up to 10 weeks
|
Questionnaire assessing the experience of the game.
|
Up to 10 weeks
|
Mood-Depression-Beck Depression Inventory-II
Time Frame: Up to 10 weeks
|
21-item inventory that asks respondents to rate on a scale of 0 (no depressive feelings) to 3 (most depressive feelings) their feelings towards various aspects of daily living/situations.
Higher total scores indicate worse depressive symptoms.
|
Up to 10 weeks
|
Alcohol Use - Alcohol Use Disorder Test
Time Frame: Baseline
|
10-item questionnaire that assess the frequency of alcohol use and problems associated with alcohol use over the past year.
|
Baseline
|
Physical Activity - International Physical Activity Questionnaire
Time Frame: Up to 10 weeks
|
7- item questionnaire assessing the different kinds of physical activities that the participant does as pat of their everyday life.
|
Up to 10 weeks
|
Personality - Big Five Inventory
Time Frame: Baseline
|
10 question assessment measuring personality.
|
Baseline
|
COVID-19 related media exposure and risk questions
Time Frame: Up to 10 weeks
|
20- item questionnaire assessing the effects of news and social media on perception of COVID-19.
|
Up to 10 weeks
|
Subjective Intervention Efficacy- Internet Intervention Utility Questionnaire
Time Frame: Up to 10 weeks
|
16- item questionnaire about the use of the intervention.
|
Up to 10 weeks
|
Computer Proficiency- Computer Proficiency Questionnaire
Time Frame: Baseline
|
This questionnaire asks about participants' ability to perform a number of tasks with a computer.
Will be examined as a covariate.
|
Baseline
|
Subjective Behavioral Sleep- Insomnia Severity Index
Time Frame: Up to 10 weeks
|
Brief self-report measure of current perception of insomnia symptom severity, distress and daytime impairment.
Commonly used in insomnia treatment outcome research.
|
Up to 10 weeks
|
Beck Depression Inventory-2nd Edition
Time Frame: Up to 10 weeks
|
21-item inventory that asks respondents to rate on a scale of 0 (no depressive feelings) to 3 (most depressive feelings) their feelings towards various aspects of daily living/situations.
Higher total scores indicate worse depressive symptoms.
|
Up to 10 weeks
|
Subjective Behavioral Sleep - Electronic Daily Sleep Diaries
Time Frame: Up to 10 weeks
|
Online diaries completed each morning (~5 mins); diaries measure sleep onset latency, wake time after sleep onset, total sleep time, and sleep quality.
|
Up to 10 weeks
|
Subjective Behavioral Sleep - Electronic Daily Sleep Diaries
Time Frame: Up to 10 weeks
|
Online diaries completed each morning (~5 mins); diaries measure sleep onset latency
|
Up to 10 weeks
|
Subjective Behavioral Sleep - Electronic Daily Sleep Diaries
Time Frame: Up to 10 weeks
|
Online diaries completed each morning (~5 mins); diaries measure wake time after sleep onset
|
Up to 10 weeks
|
Subjective Behavioral Sleep - Electronic Daily Sleep Diaries
Time Frame: Up to 10 weeks
|
Online diaries completed each morning (~5 mins); diaries measure total sleep time
|
Up to 10 weeks
|
Subjective Behavioral Sleep - Electronic Daily Sleep Diaries
Time Frame: Up to 10 weeks
|
Online diaries completed each morning (~5 mins); diaries measure sleep quality
|
Up to 10 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 8, 2020
Primary Completion (Actual)
June 30, 2022
Study Completion (Actual)
June 30, 2022
Study Registration Dates
First Submitted
June 2, 2020
First Submitted That Met QC Criteria
June 4, 2020
First Posted (Actual)
June 9, 2020
Study Record Updates
Last Update Posted (Actual)
March 15, 2023
Last Update Submitted That Met QC Criteria
March 14, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021943
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Generalized Anxiety Disorder
-
ProofPilotFisher WallaceActive, not recruitingGeneralized Anxiety Disorder | Anxiety | Generalized AnxietyUnited States
-
Xijing HospitalRecruitingGeneralized Anxiety DisorderChina
-
Sichuan Jishengtang Pharmaceutical Co., Ltd.Not yet recruitingGeneralized Anxiety Disorder
-
Hospital de Clinicas de Porto AlegreRecruitingGeneralized Anxiety DisorderBrazil
-
University of California, Los AngelesMedical University of South Carolina; Massachusetts General HospitalRecruitingGeneralized Anxiety DisorderUnited States
-
Shahid Beheshti University of Medical SciencesCompletedGeneralized Anxiety DisorderIran, Islamic Republic of
-
Dr. Nazanin AlaviOnline PsychoTherapy ClinicCompletedGeneralized Anxiety DisorderCanada
-
Laureate Institute for Brain Research, Inc.National Institute of Mental Health (NIMH)CompletedGeneralized Anxiety DisorderUnited States
-
The Canadian College of Naturopathic MedicineMassachusetts General Hospital; McGill University; Mitacs; Ekhagastiftelsen; Netherlands... and other collaboratorsActive, not recruitingGeneralized Anxiety DisorderCanada
Clinical Trials on Cognitive Training
-
Science and Research Centre KoperAlbert Einstein College of Medicine; University of Primorska; Vrije Universiteit...CompletedEffects of Cognitive Intervention on Cognition, Mobility and Brain Electrocortical Activity (GIBKOP)Cognitive Impairment | Aging | Cognitive Decline | Motor Coordination or FunctionSlovenia
-
Hospital de Clinicas de Porto AlegreYale UniversityUnknownAttention-deficit/Hyperactivity Disorder.Brazil
-
Universidade Federal do Rio de JaneiroUnknown
-
Chang Gung Memorial HospitalRecruitingVirtual Reality | Community-dwelling ElderlyTaiwan
-
Xuanwu Hospital, BeijingRecruitingMild Cognitive ImpairmentChina
-
Fundació Sant Joan de DéuCompletedIndication for Modification of Patient Cognitive StatusSpain
-
Chiang Mai UniversityCompletedMild Cognitive ImpairmentThailand
-
Chang Gung Memorial HospitalRecruitingMCI | SCD | Virtual RealityTaiwan
-
University of California, San FranciscoCompletedSchizophrenia | PsychosisUnited States
-
VA Office of Research and DevelopmentCompleted